Esperion Therapeutics
ESPR
#6169
Rank
โ‚น79.43 B
Marketcap
โ‚น335.09
Share price
-1.58%
Change (1 day)
18.47%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2025 (TTM): -โ‚น2.38 Billion

According to Esperion Therapeutics's latest financial reports the company's current earnings are โ‚น0.30 Billion. In 2024 the company made an earning of โ‚น0.67 Billion, an increase over its 2023 earnings that were of -โ‚น13.5 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น2.38 Billion-452.4%
2024 โ‚น0.67 B-104.99%
2023 -โ‚น13.5 Billion-15.03%
2022 -โ‚น15.89 Billion-20.61%
2021 -โ‚น20.02 Billion84.28%
2020 -โ‚น10.86 Billion35.75%
2019 -โ‚น8 Billion-55.71%
2018 -โ‚น18.07 Billion19.57%
2017 -โ‚น15.11 Billion125.39%
2016 -โ‚น6.71 Billion51.43%
2015 -โ‚น4.43 Billion36.45%
2014 -โ‚น3.25 Billion43.55%
2013 -โ‚น2.26 Billion145.26%
2012 -โ‚น0.93 Billion
2002 -โ‚น2.63 Billion-7.81%
2001 -โ‚น2.85 Billion15.03%
2000 -โ‚น2.48 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-โ‚น46.6 Billion 1,790.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น61.02 B-2,575.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.064 T-43,290.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น462.21 B-18,849.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น0.44 B-118.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-โ‚น6.17 Billion 149.91%๐Ÿ‡บ๐Ÿ‡ธ USA